Company intelligence / Profile preview

ChrysCapital

Mumbai, India

Ownership: Private
Development stage: Other

Overview

ChrysCapital is a private equity investment firm, not a biotech, pharma, or healthcare company. It invests in and manages portfolios of companies across multiple sectors, with significant exposure to pharmaceuticals and healthcare services in India. The company itself does not develop drugs, conduct clinical trials, or have pipeline programs.

Industry: Investors

Partnerships

Intas PharmaceuticalsTorrent PharmaceuticalsCadilaMankind PharmaEris LifesciencesCORONA PharmaceuticalsKrishna Institute of Medical Sciences (KIMS)GVK BiosciencesXoriantWOW Skin Science

Beyond the preview

Go deeper on ChrysCapital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ChrysCapital.

Explore the full profile